Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Lower LDL-c levels predict higher COVID-19 mortality.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 may cause temporary hair loss in some people.

Hydroxychloroquine may help COVID-19 patients with lupus.